BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
10 results:

  • 1. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
    Li Y; Gao X; Guo T; Liu J
    Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Coexisting Papillary and Anaplastic thyroid cancer: Elucidating the Spectrum of Aggressive Behavior.
    Greenberg JA; Moore MD; Thiesmeyer JW; Egan CE; Lee YJ; Christos P; Zarnegar R; Beninato T; Fahey Iii TJ; Finnerty BM
    Ann Surg Oncol; 2023 Jan; 30(1):137-145. PubMed ID: 36224511
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0).
    Gao X; Luo W; He L; Yang L
    Front Endocrinol (Lausanne); 2022; 13():967062. PubMed ID: 36111297
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study.
    Oliinyk D; Augustin T; Rauch J; Koehler VF; Belka C; Spitzweg C; Käsmann L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3527-3547. PubMed ID: 35960373
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated thyroid cancer Patients: A Retrospective Study in Southwest China.
    Liu Q; Yin M; Li G
    Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dynamic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary thyroid Carcinoma.
    Zhuo X; Yu J; Chen Z; Lin Z; Huang X; Chen Q; Zhu H; Wan Y
    Otolaryngol Head Neck Surg; 2022 Mar; 166(3):444-453. PubMed ID: 34058905
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Breast cancer and thyroid diseases: analysis of 867 consecutive cases.
    Chiappa C; Rovera F; Rausei S; Del Ferraro S; Fachinetti A; Lavazza M; Marchionini V; Arlant V; Tanda ML; Piantanida E; Kim HY; Anuwong A; Dionigi G
    J Endocrinol Invest; 2017 Feb; 40(2):179-184. PubMed ID: 27624298
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Necessity of central lymph node dissection in management of papillary thyroid microcarcinoma].
    Xu X; Jiang B; Han L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):362-5. PubMed ID: 24961119
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
    Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
    Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
    Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.